| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10856-007-0148-8 |
| P698 | PubMed publication ID | 17387586 |
| P50 | author | Klaus-Peter Schmitz | Q26876983 |
| Katrin Sternberg | Q114017436 | ||
| P2093 | author name string | Thomas Langer | |
| Niels Grabow | |||
| Sven Kramer | |||
| Claudia Nischan | |||
| Gerhard Hennighausen | |||
| P2860 | cites work | Physical characterization of controlled release of paclitaxel from the TAXUS Express2 drug-eluting stent. | Q31122959 |
| Mechanical properties of laser cut poly(L-lactide) micro-specimens: implications for stent design, manufacture, and sterilization | Q31168200 | ||
| Biodegradable stents: the future of interventional cardiology? | Q33568872 | ||
| Stent development and local drug delivery | Q34470332 | ||
| Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group | Q34925025 | ||
| Drug-eluting stents in vascular intervention | Q35053441 | ||
| Biodegradable stents as a platform to drug loading | Q35080390 | ||
| Drug-eluting stents: a new treatment in the prevention of restenosis. Part I: Experimental studies | Q35696122 | ||
| Drug-eluting stents: a new treatment in the prevention of restenosis. Part II: Clinical studies | Q35771400 | ||
| Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study | Q36837907 | ||
| Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study | Q38525562 | ||
| Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine. | Q39369048 | ||
| Fabrication of resorbable microporous intravascular stents for gene therapy applications. | Q41455850 | ||
| Determination of cyclosporin A in human and mouse plasma by reversed-phase high-performance liquid chromatography | Q43800574 | ||
| Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-L-lactic acid stents in rabbit urethra | Q44119342 | ||
| Effect of gamma, ethylene oxide, electron beam, and plasma sterilization on the behaviour of SR-PLLA fibres in vitro | Q44295251 | ||
| Effect of carvedilol alone or in the presence of cyclosporine on the migration of vascular smooth muscle cell of rat. | Q44319147 | ||
| Bioreabsorbable Polymer Scaffold as Temporary Meniscal Prosthesis | Q44444319 | ||
| In vitro hemocompatibility studies of drug-loaded poly-(l-lactic acid) fibers | Q44624936 | ||
| Preparation and in vitro release behaviour of 5-fluorouracil-loaded microspheres based on poly (L-lactide) and its carbonate copolymers | Q44640325 | ||
| Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease | Q44790568 | ||
| In vitro and in vivo degradation studies for development of a biodegradable patch based on poly(3-hydroxybutyrate). | Q45948778 | ||
| Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans | Q46771827 | ||
| Biomechanical study of a poly-L-lactide (PLLA) sternal pin in sternal closure after cardiothoracic surgery | Q47226744 | ||
| Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low-molecular-weight polylactides | Q47302481 | ||
| Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. | Q51637348 | ||
| Bioabsorbable screw fixation in coracoclavicular ligament reconstruction. | Q51792768 | ||
| Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model | Q56945326 | ||
| Evaluation of poly(L-lactic acid) as a material for intravascular polymeric stents | Q68100043 | ||
| Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study | Q71571194 | ||
| Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA) | Q72287836 | ||
| Anti-restenosis Trials | Q73238176 | ||
| Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor | Q73386800 | ||
| [Biodegradable ureteral stents in treating patients with infravesical obstruction] | Q73624249 | ||
| Strength retention properties of self-reinforced poly L-lactide (SR-PLLA) sutures compared with polyglyconate (Maxon) and polydioxanone (PDS) sutures. An in vitro study | Q74186662 | ||
| A 5-year in vitro and in vivo study of the biodegradation of polylactide plates | Q74557843 | ||
| Cyclosporine A stimulates proliferation of vascular smooth muscle cells and enhances monocyte adhesion to vascular smooth muscle cells | Q74616554 | ||
| Structured drug-loaded bioresorbable films for support structures | Q77217674 | ||
| The impact of material characteristics on the mechanical properties of a poly(L-lactide) coronary stent | Q78573508 | ||
| In vitro study of drug-loaded bioresorbable films and support structures | Q78765272 | ||
| A bioabsorbable self-expandable, self-reinforced poly-L-lactic acid urethral stent for recurrent urethral strictures: long-term results | Q78834008 | ||
| P433 | issue | 7 | |
| P921 | main subject | cyclosporine | Q367700 |
| P304 | page(s) | 1423-1432 | |
| P577 | publication date | 2007-03-27 | |
| P1433 | published in | Journal of Materials Science: Materials in Medicine | Q6295496 |
| P1476 | title | In vitro study of drug-eluting stent coatings based on poly(L-lactide) incorporating cyclosporine A - drug release, polymer degradation and mechanical integrity. | |
| P478 | volume | 18 |
| Q42452622 | Biodegradable polymeric coatings on cochlear implant surfaces and their influence on spiral ganglion cell survival |
| Q87934578 | Coating and Pharmacokinetic Evaluation of Air Spray Coated Drug Coated Balloons |
| Q38800294 | Current requirements for polymeric biomaterials in otolaryngology |
| Q34440106 | Development and characterization of a coronary polylactic acid stent prototype generated by selective laser melting |
| Q59009797 | Development andIn VitroCharacterization of Hyaluronic Acid-Based Coatings for Implant-Associated Local Drug Delivery Systems |
| Q59761571 | Development of a specially tailored local drug delivery system for the prevention of fibrosis after insertion of cochlear implants into the inner ear |
| Q46986146 | Improving smooth muscle cell exposure to drugs from drug-eluting stents at early time points: a variable compression approach |
| Q46783365 | In vitro study of dual drug-eluting stents with locally focused sirolimus and atorvastatin release. |
| Q38017707 | In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing. |
| Q42909014 | Novel poly(L-lactide-co-ε-caprolactone) matrices obtained with the use of Zr[Acac]₄ as nontoxic initiator for long-term release of immunosuppressive drugs |
| Q37872741 | Stents as a platform for drug delivery |
| Q46318150 | Use of a novel anti-proliferative compound coated on a biopolymer to mitigate platelet-derived growth factor-induced proliferation in human aortic smooth muscle cells: comparison with sirolimus |
| Q84638012 | [Development of a glaucoma microstent with drainage into the suprachoroidal space: fluid mechanical model approach] |
Search more.